Docetaxel combined with silver nanoparticles for synergistic therapy of prostate cancer via effectively inhibiting cell proliferation and inducing apoptosis
Although docetaxel (DTX) is a first-line chemotherapeutic agent for treating prostate cancer (PCa), its clinical effectiveness is hampered by patients developing resistance following long-term, high-dose use. Additionally, its low bioavailability and significant toxicity further restrict its therape...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Materials & Design |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0264127525003739 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|